BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37958360)

  • 1. Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
    van Dorp M; Trimbos C; Schreurs WH; Dickhoff C; Heineman DJ; Torensma B; Kazemier G; van den Broek FJC; Slotman BJ; Dahele M
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage surgery for local recurrences after stereotactic ablative radiotherapy of colorectal pulmonary metastases.
    van Dorp M; Ünal S; Gooijer S; Dickhoff C; van den Broek FJC; Kazemier G; Schreurs WH; Schneiders FL; Dahele M; Heineman DJ
    J Surg Oncol; 2023 Dec; 128(7):1114-1120. PubMed ID: 37477423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
    Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
    Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
    Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
    Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.
    Pasalic D; Betancourt-Cuellar SL; Taku N; Ludmir EB; Lu Y; Allen PK; Tang C; Antonoff MB; Fuller CD; Rosenthal DI; Morrison WH; Phan J; Garden AS; Welsh JW; Chang JY; Liao Z; Erasmus JJ; Nguyen QN
    Head Neck; 2020 Aug; 42(8):1939-1953. PubMed ID: 32129548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression.
    Ho CB; Tsai JT; Chen CY; Shiah HS; Chen HY; Ting LL; Kuo CC; Lai IC; Lai HY; Chung CL; Lee KL; Tzeng HE; Lee KH; Lee HL; Chen SW; Chiou JF
    Diagnostics (Basel); 2023 Apr; 13(9):. PubMed ID: 37174988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
    Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
    BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases.
    McDermott RL; Dunne EM; Zhao Y; Bergman A; Liu MC; Schellenberg D; Ma RM
    Clin Colorectal Cancer; 2023 Mar; 22(1):120-128. PubMed ID: 36526537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
    Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
    Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiotherapy in oligometastatic cancer.
    Kennedy TAC; Corkum MT; Louie AV
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S16. PubMed ID: 28917254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
    Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
    Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study.
    Blake-Cerda M; Lozano-Ruíz F; Maldonado-Magos F; de la Mata-Moya D; Díaz-García D; Lara-Mejía L; Zatarain-Barrón ZL; Cuevas-Góngora MF; Barron-Barron F; Corona-Cruz JF; Cabrera-Miranda L; Arroyo-Hernández M; Gerson R; Arrieta O
    Lung Cancer; 2021 Feb; 152():119-126. PubMed ID: 33385737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer.
    Hannan R; Christensen M; Christie A; Garant A; Pedrosa I; Robles L; Mannala S; Wang C; Hammers H; Arafat W; Courtney K; Bowman IA; Sher D; Ahn C; Cole S; Choy H; Timmerman R; Brugarolas J
    Eur Urol Oncol; 2022 Dec; 5(6):695-703. PubMed ID: 35985982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer.
    Cho JH; Kim S; Namgung M; Choi YS; Kim HK; Zo JI; Shim YM; Kim J
    World J Surg Oncol; 2015 Jul; 13():222. PubMed ID: 26205014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of stereotactic ablative radiotherapy (SABR) for metastatic lung lesions (MLLs) in comparison with a contemporaneous cohort of primary lung lesions (PLLs).
    Oskan F; Dzierma Y; Wagenpfeil S; Rübe C; Fleckenstein J
    J Thorac Dis; 2017 Mar; 9(3):742-756. PubMed ID: 28449482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study.
    Nicosia L; Franceschini D; Perrone-Congedi F; Molinari A; Gerardi MA; Rigo M; Mazzola R; Perna M; Scotti V; Fodor A; Iurato A; Pasqualetti F; Gadducci G; Chiesa S; Niespolo RM; Bruni A; Cappelli A; D'Angelo E; Borghetti P; Di Marzo A; Ravasio A; De Bari B; Sepulcri M; Aiello D; Mortellaro G; Sangalli C; Franceschini M; Montesi G; Aquilanti FM; Lunardi G; Valdagni R; Fazio I; Scarzello G; Vavassori V; Maranzano E; Maria Magrini S; Arcangeli S; Gambacorta MA; Valentini V; Paiar F; Ramella S; Di Muzio NG; Loi M; Jereczek-Fossa BA; Casamassima F; Osti MF; Scorsetti M; Alongi F
    Clin Transl Radiat Oncol; 2023 Mar; 39():100568. PubMed ID: 36935855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical therapy of pulmonary metastases of colorectal cancer--ten-year results].
    Vodicka J; Spidlen V; Simánek V; Safránek J; Treska V; Skalický T; Sutnar A; Fichtl J; Mukensnabl P
    Rozhl Chir; 2012 Feb; 91(2):81-6. PubMed ID: 22746086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
    Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
    Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy.
    Benson KRK; Sandhu N; Zhang C; Ko R; Toesca DAS; Lee PE; Von Eyben R; Diehn M; Gensheimer M; Maxim PG; Bush K; Loo BW; Soltys SG; Pollom EL; Chang DT
    Am J Clin Oncol; 2021 Nov; 44(11):559-564. PubMed ID: 34534143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases.
    Sutera P; Kalash R; Clump DA; D'Ambrosio D; Mihai A; Burton SA; Heron DE
    Adv Radiat Oncol; 2019; 4(1):57-62. PubMed ID: 30706011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.